Tuesday, 05 July 2022

Bert Labs announces strategic senior-level appointments

18 May 2022 | News

Dr Dinabandhu Naskar, Director & Bert Evangelist, Pharma Research, Dr Rudresha Prasad, Director & Bert Evangelist, Pharma Manufacturing and Mr Shailendra Borole, Bert Evangelist, Pharma Engineering, join the team

(L-R) Dr Dinabandhu Naskar, Dr Rudresha Prasad, Shailendra Borole

(L-R) Dr Dinabandhu Naskar, Dr Rudresha Prasad, Shailendra Borole

Bert Labs has appointed, Dr Dinabandhu Naskar as Director & Bert Evangelist, Pharma Research, Dr Rudresha Prasad as Director & Bert Evangelist, Pharma Manufacturing, and Shailendra Borole as Bert Evangelist, Pharma Engineering. This appointment comes as Bert Labs continues to explore applications of Bert Platform Solution in several industry verticals and line with its domain led growth strategy.

Dr Naskar, who is Director & Bert Evangelist – Pharma Research, was VP, Syngene (a Bicocon Company), in his 20+ years of experience as Lead Investigator & Senior Scientist in Drug Discovery & Development. He has a PhD from the Indian Institute of Chemical Technology, Hyderabad and a Post-Doctoral Fellowship from the University of Gottingen, in Germany.
 
Dr Prasad is Director & Bert Evangelist – Pharma Manufacturing. Prasad was VP, GSK, responsible for the technical process of all manufacturing plants in India. He has a PhD from IISc and two Post-Doctoral Fellowships from the University of Strathclyde and Oxford University.
 
Borole is Bert Pharma HVAC/Utility Expert. Borole was responsible for 21 years for projects and engineering at Cipla.
 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account